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Background: Depression is common in multiple sclerosis (MS); 
however, its assessment is complicated by biological processes. In this 
context it is important to consider the performance of depression 
screening measures including that their factor structure is consistent 
with expectation.  This study sought to identify the factor structure of 
the Center for Epidemiological Study - Depression Scale (CES-D) in 
people with MS (PwMS). 
Methods: Participants (N = 493) were those who had consented to 
take part in a large three-phase longitudinal study of depression in 
PwMS. CES-D questionnaires completed at phase 1 of the study were 
utilised. An error in the questionnaire meant it was most appropriate 
to consider data for 19 of the 20 CES-D questionnaire items. The data 
was split into two samples by a random selection process to create an 
exploratory, model development sample and a validation sample. The 
first sample was subject to confirmatory factor analysis. Following 
examination of model fit and specification errors, the original model 
was modified. The revised model was tested in the confirmation 
sample to assess reproducibility. 
Results: The analysis results supported the original four factor 
solution for the CES-D, that is: Depressed Affect, Positive Affect, 
Somatic Complaints/Activity Inhibition, and Interpersonal Difficulties. 
Conclusions: The CES-D appears to have a coherent structure with 
which to examine depression in PwMS.
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Introduction
Multiple sclerosis (MS), a disease of the central nervous system, 
involves a variety of debilitating physical, sensory, cognitive and 
emotional symptoms. People with MS (PwMS) are typically 
diagnosed aged 20–40 years and often face psychosocial con-
sequences including disruptions to life goals, education/ 
employment, income, relationships, leisure activities, and daily 
living activities1. Indeed, MS is considered the leading cause of 
disability in young adults in the developed world2. Furthermore, 
the chronic and unpredictable course of MS and side effects of 
MS-related medications have profound social and psychological 
consequences3.
Depression is common in PwMS with a point prevalence rate 
of up to 40% and up to 50% experiencing it at some time post 
diagnosis4,5. Depression is also associated with higher suicidal 
ideation and attempts in pwMS6 and often disrupts relation-
ships and reduces compliance with MS disease-modifying 
treatments7. The negative sequelae associated with depressive 
symptoms in MS also include decreased perceived cognitive 
function8, increased fatigue9, and sleep difficulties10.
Depressive symptoms in MS may not only be caused by the 
psychosocial adjustment to the illness and its affects but in 
relate to biological aspects of the disease11. Organic changes, 
including in, neuroendocrine function, inflammatory process and 
brain associated brain damage likely to play a role12–14.
Depression is assessed by clinical interviews but is more often 
assessed (especially in research contexts) through self-report 
questionnaires. There is a significant overlap between the somatic 
symptoms common to depression and MS symptoms, princi-
pally fatigue, poor sleep and concentration. This overlap has 
led to concerns over the accuracy of assessment of depression 
in PwMS15. Furthermore, some self-report measures of depres-
sion include questions about health and work difficulties, which 
are also impacted by MS-related physical disability16. As such, 
levels of depression in MS may be over- or underestimated, 
particularly when using self-report measures.
Despite the Center for Epidemiological Studies - Depression 
Scale (CES-D)17 originally being developed for use with the 
general community18 it has become to widely used in clini-
cal research and practice settings, including with PwMS19. The 
original CES-D is a 20-item self-reported scale that has been 
shown to measure depressive symptoms across four domains: 
Depressed Affect, Positive Affect, Somatic Complaints/Activ-
ity Inhibition, and Interpersonal Difficulties18. The four original 
latent factors have been replicated in numerous populations20. 
However, a number of other studies have yielded different 
CES-D factor structures. For instance a three-factor solution was 
evident in Chinese adolescents21 and as many as five factors has 
been found in a random sample of adults in the USA22. Some 
studies have also shown the presence of variation in the items 
comprising each factor23,24 and the magnitude of item loadings 
has varied across clinical groups25. Variations such as these may 
affect the sensitivity and specificity of this instrument in detect-
ing depressive symptoms in different populations and question 
the test’s validity. With respect to PwMS, Amtmann et al.26 
confirmed acceptable inter-item reliability and convergent/ 
discriminant validity of the CES-D in a sample of 455 patients. 
However, in this study, confirmatory factor analysis was only 
used to consider the presence of a single factor, depression, i.e., 
unidimensionality. One study considered the multi-dimensional 
factor structure of the French version of the CES-D in people 
with MS, confirming the initially identified four factor structure27.
Consistent with concerns that different populations can produce 
different factor analytic structures for measures28,29 and this 
pertains to validity30, the current study aimed to assess whether 
the four-factor model of depression is supported in PwMS in an 
English language version of the CES-D.
Methods
The research was approved by the University of Surrey Advisory 
Committee on Ethics [ACE/99/30/Psych]. Participants were 
those who had provided written, informed consent to take part in 
a large three-phase longitudinal study of depression in PwMS 
commencing in 199931 Participants were required to have a 
diagnosis of MS and be 18 years or older. Only participants under 
the age of 65 years were included in the current study. Partici-
pants were a convenience sample who self-referred to the study 
following the publication of an article in an MS magazine 
available to people in the United Kingdom. Data, including the 
CES-D, were collected yearly by postal survey using a prepaid 
system, on three occasions. The CES-D data collected at 
phase 1 are reported here. No power analysis to determine 
sample size was calculated a priori.
Measures
The CES-D17 requests the self-reporting of depressive symp-
toms experienced over the previous week. The 20 items are rated 
on a ‘0’ to ‘3’ scale, with a higher rating indicating greater 
symptom frequency. Scores can range from 0 to 60. The CES-D 
is considered to be relatively unaffected by somatic variables32 
and has been used in studies considering depression in PwMS19.
Data analysis
Data analysis was performed using SPSS v25. The data set 
was split into two by a random selection process to create an 
exploratory model development sample and the validation sam-
ple. In the exploratory stage, a model based on Radloff’s17 
original specification of the CES-D was tested using confirma-
tory factor analysis (CFA). Model fit and the degree of specifi-
cation errors were examined and modifications of the original 
model made as indicated and re-tested in the exploratory sample. 
This specification search involved examination of modification 
indices, identification of non-significant paths and conceptual 
acceptability. In the second stage, the revised model was tested 
in the confirmation sample to assess reproducibility. Models 
were estimated using maximum likelihood estimation and ade-
quacy of fit was assessed using criteria proposed by Hu and 
Bentler33 for CFA models. These criteria of goodness of fit are a 
non-normed fit index/Tucker Lewis index (NNFI/TLI) >0.95, 
comparative fit index (CFI) >0.95, root mean square error of 
approximation (RMSEA) <0.06 and standardized root mean square 
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residual (SRMR) <0.08. For completeness we also report the 
traditional chi-square fit index and the reduced chi-squared 
statistics (χ2/df), which should ideally be less than 234. To 
determine internal reliability of each factor Cronbach’s alpha 
coefficients were calculated. Due to a typographical error in one 
of the items (item 10: ‘I felt fearful’ was printed as ‘I felt 
tearful’) in the questionnaire useda, which was only observed after 
data collection; this item had to be removed, and the analyses 
are reported on the 19 items. The exploratory and confirmatory 
factor analyses were performed again on the full 20 items.
Results
Participants
A total of 493 participants were recruited (n = 399 women). 
The age range was 22 years to 65 years (mean, X = 45.8 years, 
SD = 9.25). MS diagnoses sub-types were as follows: 45% had 
‘relapsing remitting type’, 20% had ‘secondary progressive 
type’, 10% has ‘primary progressive type’, and 19% ‘did not know’ 
their MS sub-type, with 5% ‘missing data’. Over half (62.9%) 
of participants scored >16 on the CES-D, the cut off indicating 
‘significant depressive symptoms’ (X = 22.1, SD = 12.57, 
Range 0–59).
Data set
Since there was only one sample for factor analyses, both 
exploratory and confirmatory, the original data set consisting 
of 493 patients was split into two using SPSS’s random selec-
tion process. Only cases with complete data on all 20 CES-D 
items (n = 472) were retained and as a result, a model speci-
fication sample with 235 participants was generated and the 
remaining 237 were used as the validation sample. 
Confirmatory factor analysis in the exploration sample
Following Radloff’s17 exploratory factor analyses we assessed 
the fit of our data to her original model with the omission of 
item 10. Table 1 gives the fit indices for this initial model 
(Model 1). These indices suggest that the model, while not 
unreasonable in terms of the absolute size of the indices, is 
mis-specified. A specification search suggested that the two 
Somatic Symptoms items ‘I felt everything that I did was an effort 
(CESD7)’ and ‘I could not get going (CESD20)’ shared 
variance not entirely captured by the Somatic Symptoms 
factor (MI = 10.21) so a second model with this term added was 
assessed. Fit indices for this model (Model 2) are presented in 
Table 1. On Hu and Bentler’s33 four criteria this model fits 
acceptably and the χ2/df criterion is also satisfactory. No fur-
ther modifications were made as these either made trivial 
improvements in fit or did not make sense theoretically.
The re-specified model was then assessed in the confirmation 
sample (Model 3) and as seen in Figure 1, the fit indices suggest 
a satisfactory fit of this modified four-factor model. Indeed, the 
fit indices are slightly better in the confirmation sample than the 
exploratory one. The modification made in the re-specification 
process did not imply factorially complex items nor that the 
basic four-factor CES-D model was substantively incorrect, so we 
estimated the standard Cronbach’s Alpha reliability coefficients 
for the implied CES-D subscales in the confirmation sample. 
These were 0.81 for Positive Affect, 0.87 for Depressed 
Affect, 0.73 for Somatic Symptoms and 0.79 for Interpersonal 
Problems.
For the 20-item scale, following Radloff’s17 exploratory factor 
analyses we assessed the fit of our data to her original model. 
Table 2 gives the fit indices for this initial model (Model 1). 
These indices suggest that the model, while not unreasonable 
in terms of the absolute size of the indices, is mis-specified. 
A specification search suggested a substantial correlation between 
the error terms associated with the depressed affect items ‘I felt 
tearful (CESD10)’ and ‘I had crying spells (CESD17)’ 
needed to be modelled (MI = 51.92) so a second model with 
this term added was assessed. This correlated error term 
reflects the incorrect wording of Item 10 we identified in the 
Johnston et al.35 version of the CES-D we used. Fit indices 
for this model (Model 2) are presented in Table 2. On three 
of Hu and Bentler’s33 four criteria this model fits acceptable 
in the χ2/df is also satisfactory. The addition of this path in the 
model suggests that these two items share variance (r = 0.48) in 
this PwMS sample that is not captured solely by Depressed 
Affect. Further inspection of model mis-fit suggested that the 
two Somatic Symptoms items ‘I felt everything that I did was an 
effort (CESD7)’ and ‘I could not get going (CESD20)’ also 
shared variance not entirely captured by the Somatic Symptoms 
factor (MI = 11.08). Indices for this model (Model 3) are 
presented in Table 2 and Figure 2 and suggest a good fit against 
the criteria. No further modifications were made as these 
Table 1. Goodness-of-fit statistics for the models tested – with item 10 removed.
Model Description χ2 Df χ2/df NNFI/TLI CFI RMSEA SRMR
1 As specified in Radloff (1977, minus Item 10) 233.05 146 1.60 .948 .955 .050 .048
















3 Model 2 tested with the confirmation sample 
data
213.84 145 1.48 .959 .965 .045 .046
aWe used the photocopy-permitted master copy of the scale from the Measures 
in Health Psychology: A User’s Portfolio (Johnston, Wright, & Weinman, 
1995). An erratum for this measure has now been issued.
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Table 2. Goodness-of-fit statistics for the models tested – for the 20-item scale.
Model Description χ2 df χ2/df NNFI/TLI CFI RMSEA SRMR
1 As specified in Radloff1 328.04 164 2.00 0.912 0.924 0.065 0.051
2 Model 1 with correlated error terms for 
items CESD10 and CESD17
271.26 163 1.66 0.942 0.950 0.053 0.049
3 Model 2 with correlated error terms for 
items CESD7 and CESD20
255.83 162 1.58 0.949 0.957 0.050 0.046
4 Model 3 tested with the confirmation sample 
data
240.93 162 1.49 0.957 0.963 0.045 0.047
Figure 1. Revised CES-D model for People with MS – with item 10 removed. Figures are standardised maximum likelihood estimates.
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Figure 2. Revised CES-D model for People with MS – with all 20 items included. Figures are standardised maximum likelihood 
estimates.
either made trivial improvements in fit or did not make sense 
theoretically.
The re-specified model was then assessed in the confirmation 
sample (Model 4) and the fit indices suggest a satisfactory fit 
of this modified 4-factor model. Indeed, the fit indices are slightly 
better in the confirmation sample than the exploratory one. 
The modification made in the re-specification process did not 
imply factorially complex items nor that the basic 4-factor 
CES-D model was substantively incorrect, so we estimated 
the standard Cronbach’s Alpha reliability coefficients for the 
implied CES-D subscales in the confirmation sample. These 
were 0.81 for Positive Affect, 0.87 for Depressed Affect, 0.73 for 
Somatic Symptoms and 0.79 for Interpersonal Problems.
Discussion
The four-factor structure of the CES-D for the 19-item scale 
was supported by the factor analyses reported here. On the basis 
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of these results, the English version of the CES-D has factorial 
validity in PwMS. Despite the potential contribution of neu-
ropathology to symptoms, it does appear to have a coherent 
structure with which to examine depression in PwMS. Consist-
ent with Shafer20, it supports the potential for considering the 
four factors in research such as that which might consider 
whether these factors vary as part of the natural course of 
co-existent depression or indeed that considers whether 
treatments might differentially affect the factors.
The main limitation of the current study is the typographical 
error we found in the questionnaire. We did not initially spot 
the typographical error (item 10 reads “I feel tearful” when 
it should read “I feel fearful”), and only noticed it after we 
conducted our initial analyses. It should be noted the compendium 
of instruments from which the CES-D was obtained is commonly 
available: it is held in many university and clinical departments. 
On this account we have contacted the First author of the 
compendium so notifications might ensue.
Interestingly, after a brief search for studies that give details of 
the CES-D items used we note that other studies36–39 have also 
included this (or a similar) version of the questionnaire, mean-
ing their results will need to be re-evaluated. In fact, one Rasch 
analysis study using the CES-D in a rheumatoid arthritis 
sample38 found differential item functioning on this item (which 
the authors present as “I felt tearful”) for age and gender. The 
authors do suggest that this finding be replicated before a 
decision is made to remove this (and one other) item from the 
scale.
We could not complete a full review of the literature to deter-
mine how many other studies have used a version of the CES-D 
that includes the typographical error, and the impact this has 
on the findings from these studies. One of the problems is that 
not all authors report where they obtained the scale from, 
instead only citing the original reference of the scale. We were, 
however, able to spot the typo by looking for the word ‘tearful’ 
when item 10 is mentioned in the paper. On account of the 
error in the questionnaire, our modelling requires replication 
with all the full version of the CES-D. Nonetheless, despite this 
our result at this point are sufficient for us to be confident of 
how this this instrument would likely perform, that is, 
consistent with the four-factor solution.
Data availability
Underlying data
Consent was not obtained from participants for the sharing of 
their data, meaning that access to the data is restricted. Those 
wishing to access the data can apply for access. The data 
custodian is Prof Chris Fife-Schaw, University of Sur-
rey (c.fife-schaw@surrey.ac.uk). Access will be provided to 
researchers at accredited institutions.
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This is an interesting article that is looking at the factor structure of the CES-D scale for PwMS. The 
study has a really good sample size to complete the analysis and draw conclusions from. 
 
Overall the introduction seems to cover most of the literature  in the area, although the systematic 
review (Hind et al., 20161) on the reliability and validity of depression inventories for PwMS is 
missing, so the authors might want to check that they have not missed anything. Also it would be 
good to explain why the authors chose the CES-D scale rather than other depression inventories. 
 
For the Method section, there seems to be some detail, but more detail of the CES-D scale factor 
structure and the items would be good and would help understand the discussion in terms of the 
factors. In terms of the participants, it is clearly stated that this is a study that has taken place over 
a long period of time but providing a bit more detail (1) on the exact time/year; (2) over how long 
did they collect the data that are analysed in the study; (3) were there any other measurements 
collected e.g.  other depression measures or the Gold standard the interview.  
At some in the method section the authors state that "the CES-D data collected at phase 1 are 
reported here", I presume they mean the current study. 
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